Vertex Pharmaceutica
VRTX
Delayed Nasdaq - 11/21 10:00:00 pm
145.11USD
+0.32%
Prev.144.6400
Open145.7100
High146.3600
Low143.5050
Volume1 501 124
Last news
Financials
Sales 2017 2 372 M
EBIT 2017 537 M
R. net 2017 256 M
Tréso. 2017 1 079 M
Rend. 2017 -
P/E ratio 2017 154,93
P/E ratio 2018 81,50
EV / Sales 2017 15,0x
EV / Sales 2018 12,9x
Capitalization 36 699 M
Company
Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases.It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious diseases, including...
Sector :
Bio Therapeutic Drugs
Calendar :
2018-01-31 Earnings Release
Trading Rating :
Investor Rating :
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBullishBullish
Resistance155166163
Spread/Res.-6,4%-13%-11%
Spread/Supp.2,6%2,6%32%
Support141141110